• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Mersana Therapeutics Inc (NQ: MRSN )

    1.810 -0.060 (-3.21%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Mersana Therapeutics Inc

    < Previous 1 2 3 4 5 Next >
    NVIDIA To Rally Over 17%? Here Are 10 Other Analyst Forecasts For Friday
    Raymond James boosted the price target for Jabil Inc. (NYSE: JBL) from $100 to $120. Raymond James analyst Melissa Fairbanks maintained a Strong Buy rating. Jabil shares rose 5% to close at $104.64 on... 
    Via Benzinga
    Crude Oil Rises Sharply; Jabil Posts Upbeat Q3 Results
    U.S. stocks traded higher toward the end of trading, with Dow Jones gaining around 450 points on Thursday. The Dow traded up 1.32% to 34,429.39 while the NASDAQ rose 1.27% to 13,799.28. The S&P 500,... 
    Via Benzinga
    Mersana's UpRi Shows Potential in Ovarian Cancer; Analyst Initiates Coverage with Buy Rating
    Guggenheim Partners has initiated coverage on Mersana Therapeutics Inc (NASDAQ: MRSN) with a Buy rating  
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's Intraday Session
    Via Benzinga
    Mersana Therapeutics's Return On Capital Employed Insights
    Via Benzinga
    FDA Halts Mersana's Early-Stage Cancer Trial After Patient Death
    Via Benzinga
    Mersana Therapeutics's Return On Capital Employed Insights
    Via Benzinga
    Why John Wiley & Sons Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Gainers SCWorx Corp. (NASDAQ: WORX) shares jumped 281% to $0.8396. 
    Via Benzinga
    Dow Surges Over 300 Points; Kroger Profit Beats Views
    U.S. stocks traded higher midway through trading, with Dow Jones gaining more than 300 points on Thursday. The Dow traded up 0.98% to 34,313.85 while the NASDAQ rose 0.73% to 13,726.16. The S&P 500,... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For June 15, 2023
    Via Benzinga
    US Stocks Open Higher; Retail Sales Rise In May
    U.S. stocks traded higher this morning, with Dow Jones gaining around 180 points on Thursday. Following the market opening Thursday, the Dow traded up 0.53% to 34,159.59 while the NASDAQ rose 0.18% to... 
    Via Benzinga
    Coinbase Is Falling, but a Nasdaq Biotech Stock Is Thursday's Big Loser
    Markets gave back some ground after consideration of the Fed's latest interest rate decision. 
    Via The Motley Fool
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
    Via Benzinga
    Why Are Mersana Therapeutics Shares Nosediving Today
    The FDA has issued a partial clinical hold pausing new patient enrollment in Mersana Therapeutics Inc's (NASDAQ: MRSN) UP-NEXT and UPGRADE-A, the company's ongoing clinical trials of UpRi in  
    Via Benzinga
    7 Stocks to Buy for 200% Returns This Year
    These high return stock investments all have the potential to triple in 2023 based on Wall Street expectations. 
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    US Stocks Edge Higher; AMD Shares Tank Despite Upbeat Results
    U.S. stocks traded up this morning, ahead of the Federal Reserve’s decision on an interest rate hike. Following the market opening Wednesday, the Dow traded up 0.05% to 33,700.93 while the NASDAQ rose... 
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For March 16, 2023
    Via Benzinga
    With Upcoming Ovarian Cancer Data, Analyst Sees 100% Upside For Mersana Therapeutics
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    Mersana Inks Cancer Therapy Development Deal With Merck Germany
    Via Benzinga
    Recap: Mersana Therapeutics Q3 Earnings
    Mersana Therapeutics (NASDAQ:MRSN) reported its Q3 earnings results on Monday, November 7, 2022 at 07:00 AM. Here's what investors need to know about the announcement. Earnings Mersana Therapeutics... 
    Via Benzinga
    Myovant Sciences And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
    U.S. stock futures traded higher this morning. Here are some big stocks recording gains in today’s pre-market trading session. 
    Via Benzinga
    Important Biotech Catalysts For September 12, 2022 - End Of The Day Summary
    Via Benzinga
    Why Cosmos Health Shares Are Trading Lower By Around 60%? Here Are 79 Stocks Moving In Monday's Mid-Day Session
    Gainers Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) shares jumped 259% to $229.35 after the company announced resmetirom achieved both primary endpoints in NASH and liver fibrosis trial. 
    Via Benzinga
    Mersana Shares Climb As FDA Grants Fast Track Status To Triple-Negative Breast Cancer Candidate
    The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Mersana Therapeutics’ (NASDAQ: MRSN) lead candidate XMT-1660 for the treatment of adult patients with advanced or... 
    Via Benzinga
    Why Huadi International Group Shares Dipped Around 91%; Here Are 79 Biggest Movers From Yesterday
    Gainers 
    Via Benzinga
    Mersana Therapeutics's Return On Capital Employed Insights
    Mersana Therapeutics (NASDAQ:MRSN) brought in sales totaling $4.28 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 10.5%, resulting in a loss of $52.22... 
    Via Benzinga
    Why Nauticus Robotics Shares Are Trading Higher By 96%; Here Are 67 Biggest Movers From Yesterday
    Gainers Chardan NexTech Acquisition 2 Corp. (NASDAQ: CNTQ) shares surged 102.6% to close at $21.54 on Wednesday. 
    Via Benzinga
    Recap Of Tuesday's Biotech Catalysts - End Of the Day Summary
    Via Benzinga
    < Previous 1 2 3 4 5 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.